We could not find any results for:
Make sure your spelling is correct or try broadening your search.
€“ Johnson & Johnson on Monday said the European Medicines Agency's Committee for Medicinal Products for Human Use has ...
Johnson & Johnson on Wednesday reported strong fourth quarter earnings as it expressed confidence in sustaining its " ...
Johnson & Johnson on Monday said it has acquired biopharmaceutical firm Intra-Cellular Therapies Inc for a total of a ...
UK claimants Wednesday announced legal action against US pharmaceutical and cosmetics firm Johnson & Johnson, allegin ...
Johnson & Johnson on Tuesday posted weaker earnings in the first quarter despite growing sales, as research and devel ...
Johnson & Johnson on Wednesday announced the completion of its USD600 million acquisition of heart failure treatment ...
Johnson & Johnson on Tuesday announced an acquisition for its MedTech division, as well as a US approval for its lung ...
Johnson & Johnson on Wednesday reported some sales progress in the second quarter, following the completion of its US ...
Johnson & Johnson on Friday completed its acquisition of Shockwave Medical Inc, enhancing the company's cardiovascula ...
Johnson & Johnson on Wednesday proposed a USD6.48 billion settlement of tens of thousands of lawsuits which allege th ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -0.0651890482399 | 153.4 | 154.5 | 153.3 | 74855 | 153.42232969 | DE |
4 | 10 | 6.97836706211 | 143.3 | 154.5 | 143.3 | 26929 | 151.63175217 | DE |
12 | -0.5 | -0.325097529259 | 153.8 | 155.5 | 141.5 | 39139 | 149.53712968 | DE |
26 | -6 | -3.76647834275 | 159.3 | 167.7 | 141.5 | 28745 | 154.46794887 | DE |
52 | -3.2 | -2.0447284345 | 156.5 | 167.7 | 141.5 | 60650 | 158.88040147 | DE |
156 | -16.7 | -9.82352941176 | 170 | 185.96 | 141.5 | 114647 | 162.2343392 | DE |
260 | 1.42 | 0.934948643666 | 151.88 | 185.96 | 111.87 | 85615 | 162.08564585 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions